Bioqual Statistics
Total Valuation
Bioqual has a market cap or net worth of 34.44 million. The enterprise value is 31.09 million.
| Market Cap | 34.44M |
| Enterprise Value | 31.09M |
Important Dates
The last earnings date was Wednesday, January 21, 2026.
| Earnings Date | Jan 21, 2026 |
| Ex-Dividend Date | Oct 7, 2024 |
Share Statistics
Bioqual has 894,416 shares outstanding.
| Current Share Class | 894,416 |
| Shares Outstanding | 894,416 |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 39.76% |
| Owned by Institutions (%) | n/a |
| Float | 205,671 |
Valuation Ratios
The trailing PE ratio is 75.97.
| PE Ratio | 75.97 |
| Forward PE | n/a |
| PS Ratio | 0.74 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.99 |
| P/FCF Ratio | 6.89 |
| P/OCF Ratio | 6.43 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.44, with an EV/FCF ratio of 6.22.
| EV / Earnings | 68.60 |
| EV / Sales | 0.67 |
| EV / EBITDA | 4.44 |
| EV / EBIT | 246.64 |
| EV / FCF | 6.22 |
Financial Position
The company has a current ratio of 4.41, with a Debt / Equity ratio of 0.96.
| Current Ratio | 4.41 |
| Quick Ratio | 4.33 |
| Debt / Equity | 0.96 |
| Debt / EBITDA | 4.93 |
| Debt / FCF | 6.91 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.28% and return on invested capital (ROIC) is 0.16%.
| Return on Equity (ROE) | 1.28% |
| Return on Assets (ROA) | 0.12% |
| Return on Invested Capital (ROIC) | 0.16% |
| Return on Capital Employed (ROCE) | 0.19% |
| Weighted Average Cost of Capital (WACC) | 1.91% |
| Revenue Per Employee | 411,829 |
| Profits Per Employee | 4,011 |
| Employee Count | 113 |
| Asset Turnover | 0.71 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Bioqual has paid 331,453 in taxes.
| Income Tax | 331,453 |
| Effective Tax Rate | 42.24% |
Stock Price Statistics
The stock price has decreased by -40.77% in the last 52 weeks. The beta is -0.08, so Bioqual's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | -40.77% |
| 50-Day Moving Average | 59.83 |
| 200-Day Moving Average | 74.81 |
| Relative Strength Index (RSI) | 22.79 |
| Average Volume (20 Days) | 747 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.08 |
Income Statement
In the last 12 months, Bioqual had revenue of 46.54 million and earned 453,256 in profits. Earnings per share was 0.51.
| Revenue | 46.54M |
| Gross Profit | 10.70M |
| Operating Income | 126,061 |
| Pretax Income | 784,709 |
| Net Income | 453,256 |
| EBITDA | 2.42M |
| EBIT | 126,061 |
| Earnings Per Share (EPS) | 0.51 |
Balance Sheet
The company has 12.34 million in cash and 34.50 million in debt, with a net cash position of -22.16 million or -24.78 per share.
| Cash & Cash Equivalents | 12.34M |
| Total Debt | 34.50M |
| Net Cash | -22.16M |
| Net Cash Per Share | -24.78 |
| Equity (Book Value) | 35.77M |
| Book Value Per Share | 39.99 |
| Working Capital | 19.75M |
Cash Flow
In the last 12 months, operating cash flow was 5.36 million and capital expenditures -359,750, giving a free cash flow of 5.00 million.
| Operating Cash Flow | 5.36M |
| Capital Expenditures | -359,750 |
| Free Cash Flow | 5.00M |
| FCF Per Share | 5.59 |
Margins
Gross margin is 22.98%, with operating and profit margins of 0.27% and 0.97%.
| Gross Margin | 22.98% |
| Operating Margin | 0.27% |
| Pretax Margin | 1.69% |
| Profit Margin | 0.97% |
| EBITDA Margin | 5.20% |
| EBIT Margin | 0.27% |
| FCF Margin | 10.73% |
Dividends & Yields
This stock pays an annual dividend of 0.50, which amounts to a dividend yield of 1.30%.
| Dividend Per Share | 0.50 |
| Dividend Yield | 1.30% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | 1.30% |
| Earnings Yield | 1.32% |
| FCF Yield | 14.51% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 28, 1997. It was a reverse split with a ratio of 0.16666.
| Last Split Date | Oct 28, 1997 |
| Split Type | Reverse |
| Split Ratio | 0.16666 |
Scores
Bioqual has an Altman Z-Score of 2.26 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.26 |
| Piotroski F-Score | 6 |